Options
Quantifying prion disease penetrance using large population control cohorts
ISSN
1946-6242
1946-6234
Date Issued
2016
Author(s)
Minikel, Eric Vallabh
Vallabh, Sonia M.
Lek, Monkol
Estrada, Karol O.
Samocha, Kaitlin E.
Sathirapongsasuti, J. Fah
McLean, Cory Y.
Tung, Joyce Y.
Yu, Linda P. C.
Gambetti, Pierluigi
Blevins, Janis
Zhang, S.
Cohen, Yvonne
Chen, Wei
Yamada, Masahito
Hamaguchi, Tsuyoshi
Sanjo, Nobuo
Mizusawa, Hidehiro
Nakamura, Yosikazu
Kitamoto, Tetsuyuki
Collins, Steven J.
Boyd, Alison
Will, Robert G.
Knight, Richard
Kraus, Theo F. J.
Eigenbrod, Sabina
Giese, Armin
Calero, Miguel
de Pedro-Cuesta, Jesus
HaiK, Stephane
Laplanche, Jean-Louis
Bouaziz-Amar, Elodie
Brandel, Jean-Philippe
Capellari, Sabina
Parchi, Piero
Poleggi, Anna
Ladogana, Anna
O'Donnell-Luria, Anne H.
Karczewski, Konrad J.
Marshall, Jamie L.
Boehnke, Michael
Laakso, Markku
Mohlke, Karen L.
Kahler, Anna
Chambert, Kimberly
McCarroll, Steven
Sullivan, Patrick F.
Hultman, Christina M.
Purcell, Shaun M.
Sklar, Pamela
van der Lee, Sven J.
Rozemuller, Annemieke
Jansen, Casper
Hofman, Albert
Kraaij, Robert
van Rooij, Jeroen G. J.
Ikram, M. Arfan
Uitterlinden, Andre G.
van Duijn, Cornelia M.
Daly, Mark J.
MacArthur, Daniel G.
DOI
10.1126/scitranslmed.aad5169
Abstract
More than 100,000 genetic variants are reported to cause Mendelian disease in humans, but the penetrance-the probability that a carrier of the purported disease-causing genotype will indeed develop the disease-is generally unknown. We assess the impact of variants in the prion protein gene (PRNP) on the risk of prion disease by analyzing 16,025 prion disease cases, 60,706 population control exomes, and 531,575 individuals genotyped by 23andMe Inc. We show that missense variants in PRNP previously reported to be pathogenic are at least 30 times more common in the population than expected on the basis of genetic prion disease prevalence. Although some of this excess can be attributed to benign variants falsely assigned as pathogenic, other variants have genuine effects on disease susceptibility but confer lifetime risks ranging from < 0.1 to similar to 100%. We also show that truncating variants in PRNP have position-dependent effects, with true loss-of-function alleles found in healthy older individuals, a finding that supports the safety of therapeutic suppression of prion protein expression.